PENTOXIFYLLINE AND WELLBEING IN PATIENTS WITH CANCER

被引：44

作者：

DEZUBE, BJ

FRIDOVICHKEIL, JL

BOUVARD, I

LANGE, RF

PARDEE, AB

机构：

[1] HARVARD UNIV, SCH MED, DANA FARBER CANC INST, DEPT MED, BOSTON, MA 02115 USA

[2] BETH ISRAEL HOSP, DEPT MED, DIV MED ONCOL, BOSTON, MA 02215 USA

来源：

关键词：

D O I：

10.1016/0140-6736(90)90450-J

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：662 / 662

页数：1

共 6 条

[1] BALKWILL F, 1987, LANCET, V2, P1229
[2] BAUER KA, 1989, BLOOD, V74, P165
[3] BEUTLER B, 1987, NEW ENGL J MED, V316, P379
[4] PENTOXIFYLLINE PREVENTS TUMOR NECROSIS FACTOR-INDUCED LUNG INJURY
LILLY, CM
SANDHU, JS
ISHIZAKA, A
HARADA, H
YONEMARU, M
LARRICK, JW
SHI, TX
OHANLEY, PT
RAFFIN, TA
[J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 139 (06): : 1361 - 1368
[5] CELLULAR AND MOLECULAR REGULATION OF TUMOR NECROSIS FACTOR-ALPHA PRODUCTION BY PENTOXIFYLLINE
STRIETER, RM
REMICK, DG
WARD, PA
SPENGLER, RN
LYNCH, JP
LARRICK, J
KUNKEL, SL
[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 155 (03) : 1230 - 1236
[6] PENTOXIFYLLINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND ITS THERAPEUTIC EFFICACY
WARD, A
CLISSOLD, SP
[J]. DRUGS, 1987, 34 (01) : 50 - 97